Efficient functional neutralization of lethal peptide toxins in vivo by oligonucleotides

[1]  Carrie Arnold.  Vipers, mambas and taipans: the escalating health crisis over snakebites , 2016, Nature.

[2]  Carrie Arnold.  Synthetic biology tackles global antivenom shortage , 2016, Nature.

[3]  A. H. Laustsen,et al.  Selecting key toxins for focused development of elapid snake antivenoms and inhibitors guided by a Toxicity Score , 2016 .

[4]  V. C. Ozalp,et al.  Aptamers: molecular tools for medical diagnosis. , 2015, Current topics in medicinal chemistry.

[5]  C. Yang,et al.  A Controllable Aptamer-Based Self-Assembled DNA Dendrimer for High Affinity Targeting, Bioimaging and Drug Delivery , 2015, Scientific Reports.

[6]  J. Bruno.  Predicting the Uncertain Future of Aptamer-Based Diagnostics and Therapeutics , 2015, Molecules.

[7]  Moses Rodriguez,et al.  Quantitative PCR Analysis of DNA Aptamer Pharmacokinetics in Mice , 2015, Nucleic acid therapeutics.

[8]  G. King.  Venoms to Drugs: Venom as a Source for the Development of Human Therapeutics , 2015 .

[9]  P. Thapa,et al.  Conotoxins and their regulatory considerations. , 2014, Regulatory toxicology and pharmacology : RTP.

[10]  Y. Zu,et al.  Oligonucleotide Aptamers: New Tools for Targeted Cancer Therapy , 2014, Molecular therapy. Nucleic acids.

[11]  Deqiao Tian,et al.  Comparison and Analysis of Biological Agent Category Lists Based On Biosafety and Biodefense , 2014, PloS one.

[12]  J. Vivekananda,et al.  DNA aptamers as a novel approach to neutralize Staphylococcus aureus α-toxin. , 2014, Biochemical and biophysical research communications.

[13]  L. Wade.  Drug industry. For Mexican antivenom maker, U.S. market is a snake pit. , 2014, Science.

[14]  J. Byun,et al.  Nucleic Acid Aptamers: New Methods for Selection, Stabilization, and Application in Biomedical Science , 2013, Biomolecules & therapeutics.

[15]  Soonhag Kim,et al.  Bioimaging of targeting cancers using aptamer-conjugated carbon nanodots. , 2013, Chemical communications.

[16]  S. Tope,et al.  Aptamers as therapeutics , 2013 .

[17]  Christopher M. Warner,et al.  Accelerated manufacturing of large-scale, full-length, human-like glycosylated antibodies for bio-defense. , 2012 .

[18]  P. Anderson,et al.  Conotoxins: Potential Weapons from the Sea , 2012 .

[19]  Y. Rosenstein,et al.  Vm24, a Natural Immunosuppressive Peptide, Potently and Selectively Blocks Kv1.3 Potassium Channels of Human T Cells , 2012, Molecular Pharmacology.

[20]  S. Edwards,et al.  Rapid One-Step Selection Method for Generating Nucleic Acid Aptamers: Development of a DNA Aptamer against α-Bungarotoxin , 2012, PloS one.

[21]  I. Vetter,et al.  Conus Venom Peptide Pharmacology , 2012, Pharmacological Reviews.

[22]  Seonghwan Lee,et al.  Aptamers and Their Biological Applications , 2012, Sensors.

[23]  S. Edwards,et al.  Rapid One-Step Selection Method for Generating Nucleic Acid Aptamers: Development of a DNA Aptamer against alpha-Bungarotoxin , 2012 .

[24]  David J. Williams,et al.  Ending the drought: new strategies for improving the flow of affordable, effective antivenoms in Asia and Africa. , 2011, Journal of proteomics.

[25]  K. Kaestner,et al.  The International Journal of Biochemistry & Cell Biology. Preface. , 2011, The international journal of biochemistry & cell biology.

[26]  E. Peyrin,et al.  Rationally designed aptamer-based fluorescence polarization sensor dedicated to the small target analysis. , 2010, Biosensors & bioelectronics.

[27]  David J. Williams,et al.  The Global Snake Bite Initiative: an antidote for snake bite , 2010, The Lancet.

[28]  B. Lomonte,et al.  Biochemistry and toxicology of toxins purified from the venom of the snake Bothrops asper. , 2009, Toxicon : official journal of the International Society on Toxinology.

[29]  D. Bertrand,et al.  Interaction of α‐conotoxin ImII and its analogs with nicotinic receptors and acetylcholine‐binding proteins: additional binding sites on Torpedo receptor , 2009, Journal of neurochemistry.

[30]  I. D. Simpson,et al.  The Anti Snake Venom Crisis in Africa: A Suggested Manufacturers Product Guide , 2009, Wilderness & environmental medicine.

[31]  Robert Langer,et al.  Nanotechnology and Aptamers: Applications in Drug Delivery , 2022 .

[32]  Chunhai Fan,et al.  Aptamer-based biosensors , 2008 .

[33]  M. Bowser,et al.  In vitro evolution of functional DNA using capillary electrophoresis. , 2004, Journal of the American Chemical Society.

[34]  S. Grissmer,et al.  A Maurotoxin with Constrained Standard Disulfide Bridging , 2003, Journal of Biological Chemistry.

[35]  D. Warrell,et al.  Crisis in snake antivenom supply for Africa , 2000, The Lancet.

[36]  B. J. Hawgood.  Doctor Albert Calmette 1863-1933: founder of antivenomous serotherapy and of antituberculous BCG vaccination. , 1999, Toxicon : official journal of the International Society on Toxinology.

[37]  V. Sitprija,et al.  Heterologous Antisera and Antivenins Are Essential Biologicals: Perspectives on a Worldwide Crisis , 1996, Annals of Internal Medicine.

[38]  L. Smith,et al.  A study on the cause of death due to waglerin-I, a toxin from Trimeresurus wagleri. , 1995, Toxicon : official journal of the International Society on Toxinology.

[39]  O. Pagán,et al.  The alpha-conotoxins GI and MI distinguish between the nicotinic acetylcholine receptor agonist sites while SI does not. , 1994, Biochemistry.

[40]  B. Olivera,et al.  alpha-Conotoxins, small peptide probes of nicotinic acetylcholine receptors. , 1991, Biochemistry.

[41]  Y. Cheng,et al.  Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. , 1973, Biochemical pharmacology.